Literature DB >> 1329093

Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen.

M F Bierhuizen1, M Fukuda.   

Abstract

A cDNA encoding UDP-GlcNAc:Gal beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase (EC 2.4.1.102), which forms critical branches in O-glycans, has been isolated by an expression cloning approach using Chinese hamster ovary (CHO) cells. Increased activity of this enzyme and the concomitant occurrence of the O-glycan core 2 structure [Gal beta 1-3(GlcNAc beta 1-6)GalNAc] has been observed in a variety of biological processes, such as T-cell activation and immunodeficiency due to the Wiskott-Aldrich syndrome and AIDS. Since CHO cells do not express this enzyme, CHO cell lines were established to stably express polyoma large tumor (T) antigen, which enables transient expression cloning. Because the antibody used was found to detect most efficiently the oligosaccharide products attached to leukosialin, the CHO cells were also stably transfected with leukosialin cDNA. By using this particular CHO cell line, a cDNA that encodes a protein determining the formation of the core 2 structure was isolated from an HL-60 cDNA library. The cDNA sequence predicts a protein with type II membrane topology, as has been found for all other mammalian glycosyltransferases cloned to date. The expression of the presumed catalytic domain as a fusion protein with the IgG binding domain of protein A enabled us to demonstrate unequivocally that the cDNA encodes the core 2 beta-1,6-N-acetylglucosaminyltransferase, the enzyme responsible for the formation of Gal beta 1-3(GlcNAc beta 1-6)GalNAc structures. No activity with this enzyme was detected toward the acceptors for other beta 1-6GlcNAc transferases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329093      PMCID: PMC50119          DOI: 10.1073/pnas.89.19.9326

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

2.  Isolation of large T antigen-producing mouse cell lines capable of supporting replication of polyomavirus-plasmid recombinants.

Authors:  W J Muller; M A Naujokas; J A Hassell
Journal:  Mol Cell Biol       Date:  1984-11       Impact factor: 4.272

3.  Construction and applications of a highly transmissible murine retrovirus shuttle vector.

Authors:  C L Cepko; B E Roberts; R C Mulligan
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

Review 4.  Glycosylation mutants of animal cells.

Authors:  P Stanley
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

5.  Granulocytic differentiation of HL-60 cells is associated with increase of poly-N-acetyllactosamine in Asn-linked oligosaccharides attached to human lysosomal membrane glycoproteins.

Authors:  N Lee; W C Wang; M Fukuda
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

6.  Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA.

Authors:  H Sasaki; B Bothner; A Dell; M Fukuda
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

7.  Mucin synthesis. UDP-GlcNAc:GalNAc-R beta 3-N-acetylglucosaminyltransferase and UDP-GlcNAc:GlcNAc beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase from pig and rat colon mucosa.

Authors:  I Brockhausen; K L Matta; J Orr; H Schachter
Journal:  Biochemistry       Date:  1985-04-09       Impact factor: 3.162

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Biosynthesis of blood group I antigens. Identification of a UDP-GlcNAc:GlcNAc beta 1-3Gal(-R) beta 1-6(GlcNAc to Gal) N-acetylglucosaminyltransferase in hog gastric mucosa.

Authors:  F Piller; J P Cartron; A Maranduba; A Veyrières; Y Leroy; B Fournet
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

10.  Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome.

Authors:  F Piller; F Le Deist; K I Weinberg; R Parkman; M Fukuda
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

View more
  75 in total

1.  Development of monoclonal antibodies against bovine mucin core 2 beta6 N-acetylglucosaminyltransferase.

Authors:  C M Li; N Joshee; K B Adler; P W Cheng
Journal:  Glycoconj J       Date:  1999-09       Impact factor: 2.916

2.  Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N- and O-glycans in lymphocyte homing.

Authors:  Jotaro Hirakawa; Koichiro Tsuboi; Kaori Sato; Motohiro Kobayashi; Sota Watanabe; Atsushi Takakura; Yasuyuki Imai; Yuki Ito; Minoru Fukuda; Hiroto Kawashima
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

3.  Expression of stable human O-glycan core 2 beta-1,6-N-acetylglucosaminyltransferase in Sf9 insect cells.

Authors:  D Toki; M Sarkar; B Yip; F Reck; D Joziasse; M Fukuda; H Schachter; I Brockhausen
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

4.  Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration.

Authors:  Isabel Correa; Tim Plunkett; Anda Vlad; Arron Mungul; Jessica Candelora-Kettel; Joy M Burchell; Joyce Taylor-Papadimitriou; Olivera J Finn
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

5.  Peptide-specific transfer of N-acetylgalactosamine to O-linked glycans by the glycosyltransferases β1,4-N-acetylgalactosaminyl transferase 3 (β4GalNAc-T3) and β4GalNAc-T4.

Authors:  Dorothy Fiete; Mary Beranek; Jacques U Baenziger
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

Review 6.  Simple sugars to complex disease--mucin-type O-glycans in cancer.

Authors:  Matthew R Kudelka; Tongzhong Ju; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

7.  Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.

Authors:  W Kuhns; V Rutz; H Paulsen; K L Matta; M A Baker; M Barner; M Granovsky; I Brockhausen
Journal:  Glycoconj J       Date:  1993-10       Impact factor: 2.916

8.  Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor.

Authors:  Shingo Hatakeyama; Atsushi Kyan; Hayato Yamamoto; Akiko Okamoto; Naoki Sugiyama; Yuichiro Suzuki; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Shigeyuki Yamada; Hideo Saito; Yoichi Arai; Minoru Fukuda; Chikara Ohyama
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

9.  An essential role of sialylated O-linked sugar chains in the recognition of mouse CD99 by paired Ig-like type 2 receptor (PILR).

Authors:  Jing Wang; Ikuo Shiratori; Takeshi Satoh; Lewis L Lanier; Hisash Arase
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

10.  Bovine Herpesvirus 4 Modulates Its β-1,6-N-Acetylglucosaminyltransferase Activity through Alternative Splicing.

Authors:  Céline Lété; Nicolas Markine-Goriaynoff; Bénédicte Machiels; Poh-Choo Pang; Xue Xiao; Kevin Canis; Masami Suzuki; Minoru Fukuda; Anne Dell; Stuart M Haslam; Alain Vanderplasschen; Laurent Gillet
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.